Gedeon Richter

Gedeon Richter, a pharmaceutical preparation manufacturer headquartered in Hungary, is committed to reducing its environmental impact. For the reporting year 2025, the company reported approximately 294.6 million kg CO2e in total greenhouse gas emissions. This figure comprises Scope 1 emissions of around 42.8 million kg CO2e, and Scope 2 emissions (market-based) of approximately 76.7 million kg CO2e. Scope 3 emissions, which include significant contributions from purchased goods and services (approximately 96.5 million kg CO2e) and waste generated in operations (about 27.1 million kg CO2e), amounted to roughly 175 million kg CO2e.

In the preceding year, 2024, Gedeon Richter's total emissions were approximately 324.1 million kg CO2e. Scope 1 emissions stood at about 45.6 million kg CO2e, with Scope 2 emissions (market-based) at roughly 91.7 million kg CO2e. Scope 3 emissions for 2024 totalled approximately 186.8 million kg CO2e, with purchased goods and services being the largest contributor at around 83.8 million kg CO2e.

Gedeon Richter has set ambitious climate targets. The company aims to reduce its overall greenhouse gas emissions by 55% by 2030, using 2020 as a baseline. Specific to Scope 1 emissions, the goal is a 30% reduction from the 2020 baseline by 2030, with an interim aim to reduce these emissions to near zero by 2025. Similarly, Scope 2 emissions are targeted for a 30% reduction from the 2020 baseline by 2030, also with an aspiration to reach near zero by 2025. The company's disclosures indicate upstream emissions reporting for several categories, underscoring their focus on supply chain impacts. Gedeon Richter is not currently reporting cascaded emissions data from a parent organisation.